Efficacy and Safety if JAK2 Inhibitor Plus Extracorporeal Photopheresis in Chronic Lung Allograft Dysfunction: A Single Centre Experience

Purpose: Post lung transplantation survival is limited by the development of chronic lung allograft dysfunction(CLAD),for which only few effective therapies exists and no standardized management. There are studies showing proven benefits of JAK2 inhibitor plus ECP in post bone marrow transplantation GVHD patients.We analysed JAK2 inhibitor plus ECP therapy in clinically diagnosed CLAD.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , V. Rahulan, M. Lalani, O. Tisekar, S. Priyaranjan, P. Dutta, A. Mohandas, M. B N, M. M, M. Sameer, S. Attawar Source Type: research